CVS Reaches Proposed Deal with FTC to Resolve Insulin Price Inflation Allegations
- March 27, 2026
- Written by AHLA Staff
CVS Health Corp. has reached a proposed consent agreement with the Federal Trade Commission (FTC) that would resolve allegations its pharmacy benefit manager (PBM) Caremark Rx engaged in unfair trade practices, according to a March 23 filing.
ARTICLE TAGS
You must be logged in to access this content.